CeNeRx BioPharma Raises $13 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $13 million in new Series C funding (including $3m in debt). Return backers include Aisling Capital, L Capital Partners and Pappas Ventures.
13 August 2010•2 mins read
